SCHEMBL5459710

SCHEMBL5459710

Nc1nc(O)c2c(n1)CC(c1ccccc1)CC2=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.71
HSP90AB1 P08238 1/20 0.71
ALDH1A1 P00352 6/20 0.52
MAPT P10636 4/20 0.52
TSHR P16473 4/20 0.46
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
MAP1LC3B Q9GZQ8 2/20 0.42
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 1/20 0.40
HTT P42858 1/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1781499 0.83 HSP90AA1 (1.00) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL1781501 0.81 HSP90AA1 (0.64) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL5466627 0.80 HSP90AA1 (0.70) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL5477708 0.78 HSP90AA1 (0.64) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL5464887 0.77 HSP90AA1 (0.66) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL19520778 0.76 HSP90AA1 (0.61) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL5466929 0.74 HSP90AA1 (0.59) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL1780049 0.74 ALDH1A1 (0.66) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL5474355 0.74 HSP90AA1 (0.58) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR
SCHEMBL3238459 0.73 MAPT (0.48) HSP90AA1HSP90AB1ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 HSP90AA1 3373/4885HSP90AB1 3036/4885ALDH1A1 1718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.